Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Discovery Medicine|April 4, 2017
Hypermutations in gliomas: a potential immunotherapy targetGaetano Finocchiaro, Tiziana Langella, Cristina Corbetta, et al.International Journal of Molecular Sciences|October 14, 2023
Progression after First-Line Cyclin-Dependent Kinase 4/6 Inhibitor Treatment: Analysis of Molecular Mechanisms and Clinical DataFederica Villa, Alessandra Crippa, Davide Pelizzoni, et al.Acta Neuropathologica Communications|April 8, 2015
Effective immuno-targeting of the IDH1 mutation R132H in a murine model of intracranial gliomaSerena Pellegatta, Lorella Valletta, Cristina Corbetta, et al.Science Translational Medicine|March 2, 2018
Constitutive and TNFα-inducible expression of chondroitin sulfate proteoglycan 4 in glioblastoma and neurospheres: Implications for CAR-T cell therapySerena Pellegatta, Barbara Savoldo, Natalia Di Ianni, et al.International Journal of Cancer|November 13, 2018
Altered function of the glutamate-aspartate transporter GLAST, a potential therapeutic target in glioblastomaCristina Corbetta, Natalia Di Ianni, Maria Grazia Bruzzone, et al.Oncoimmunology|April 11, 2018
Survival gain in glioblastoma patients treated with dendritic cell immunotherapy is associated with increased NK but not CD8+ T cell activation in the presence of adjuvant temozolomideSerena Pellegatta, Marica Eoli, Valeria Cuccarini, et al.Neuro-Oncology Advances|July 10, 2020
Expansion of effector and memory T cells is associated with increased survival in recurrent glioblastomas treated with dendritic cell immunotherapyMarica Eoli, Cristina Corbetta, Elena Anghileri, et al.Pageof 1